Scinai Immunotherapeutics Ltd. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Scinai Immunotherapeutics Ltd. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q2 2023.
  • Scinai Immunotherapeutics Ltd. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$3.76M, a 26.1% decline year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Net Income (Loss) Attributable to Parent for 2023 was -$6.5M, a 12.1% decline from 2022.
  • Scinai Immunotherapeutics Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.8M, a 29.4% increase from 2021.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$3.76M -$779K -26.1% Apr 1, 2023 Jun 30, 2023 6-K/A 2023-08-18
Q1 2023 -$3.52M -$1.04M -42% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q2 2022 -$2.98M Apr 1, 2022 Jun 30, 2022 6-K/A 2023-08-18
Q1 2022 -$2.48M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.